Literature DB >> 4199213

Pharmacology of cefazolin in human volunteers.

P Nicholas, B R Meyers, S Z Hirschman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4199213     DOI： 10.1002/j.1552-4604.1973.tb00219.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  6 in total

1.  Dosage adjustments of cefazolin according to the pharmacokinetics of this new cephalosporin.

Authors:  J Lavillaureix; J M Brogard; M Pinget; F Ledoux
Journal:  Infection       Date:  1975       Impact factor: 3.553

2.  Pharmacokinetic interpretation of blood levels and urinary excretion data for cefazolin and cephalothin after intravenous and intramuscular administration in humans.

Authors:  E S Rattie; L J Ravin
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

3.  Pharmacological studies with cefamandole in human volunteers.

Authors:  B R Meyers; B Ribner; S Yancovitz; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

4.  Metabolic fate of [14C]cefamandole, a parenteral cephalosporin antibiotic, in rats and dogs.

Authors:  H R Sullivan; S L Due; D L Kau; J F Quay; W M Miller
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

5.  Effects of general and local anesthesia on the pharmacokinetics of cefazolin in patients undergoing orthopedic surgery.

Authors:  W D Welch; J P Jantzen; K Johnson; R E Bawdon
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

6.  Antibiotic concentration in human wound fluid after intravenous administration.

Authors:  D H Bagley; J Mac Lowry; R M Beazley; C Gorschboth; A S Ketcham
Journal:  Ann Surg       Date:  1978-08       Impact factor: 12.969
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.